Late-breaking clinical trial presented at #TCT2021

#TCT2021 SURTAVI: Five-Year Results From A Randomized Trial Of TAVR Vs. SAVR In Patients At Intermediate Surgical Risk

CRF TCT 2024  Interventional Cardiology Group

TCT 2021 Presentations

Welcome to this series which will host late-breaking clinical trials presented at TCT, the world's premier meeting for interventional cardiovascular medicine.

Adam Ali

Late Breaking Clinical Trial - Presented at #TCT2021

The FAME 3 Trial: Fractional Flow Reserve-Guided PCI Compared with Coronary Bypass Surgery

FAVOR III China: A Sham-Controlled Randomized Trial Comparing  QFR-Guided and Angiography-Guided PCI

A Double-Blind Randomized Trial Of The Effect Of Different Antiplatelet Regimens On Gastrointestinal Injury. Late-breaking trial presented at #TCT2021

#TCT2021: OPT-PEACE

Hemodynamic Guided Management of Heart Failure: Outcomes of GUIDE-HF According to Ejection Fraction. Late-breaking trial presented at #TCT2021